Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists.
Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists.
Share:
ERFURT, Germany and BERLIN, Dec. 16, 2020 /CNW/ - AMP German Cannabis Group Inc. ( AMP ) (CSE:XCX) (Frankfurt: C4T) (ISIN: CA00176G1028) is pleased to provide a letter to its shareholders.
XCX) Logo (CNW Group/AMP German Cannabis Group Inc.) alt= AMP German Cannabis Group (CSE:XCX) Logo (CNW Group/AMP German Cannabis Group Inc.) >Dear Shareholders,
The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally.
AMP s focus has always been to supply German patients with the highest quality cannabis products available. Our strength is having front-line relationships with the distributors of medical cannabis to pharmacies, the only point-of-sale for medical cannabis to German patients, which allows us to respond to market changes quickly.